| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.004 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.007 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |